The ABP Dendrimer, a Drug-Candidate against Inflammatory Diseases That Triggers the Activation of Interleukin-10 Producing Immune Cells
The ABP dendrimer, which is built on a phosphorus-based scaffold and bears twelve azabisphosphonate groups at its surface, is one of the dendrimers that has been shown to display immuno-modulatory and anti-inflammatory effects towards the human immune system. Its anti-inflammatory properties have be...
Main Authors: | Séverine Fruchon, Rémy Poupot |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2018-05-01
|
Series: | Molecules |
Subjects: | |
Online Access: | http://www.mdpi.com/1420-3049/23/6/1272 |
Similar Items
-
Biodistribution and Biosafety of a Poly(Phosphorhydrazone) Dendrimer, an Anti-Inflammatory Drug-Candidate
by: Séverine Fruchon, et al.
Published: (2019-09-01) -
Pro-Inflammatory Versus Anti-Inflammatory Effects of Dendrimers: The Two Faces of Immuno-Modulatory Nanoparticles
by: Séverine Fruchon, et al.
Published: (2017-09-01) -
Repolarization of Unbalanced Macrophages: Unmet Medical Need in Chronic Inflammation and Cancer
by: Yannick Degboé, et al.
Published: (2022-01-01) -
An Azabisphosphonate-Capped Poly(phosphorhydrazone) Dendrimer for the Treatment of Endotoxin-Induced Uveitis
by: Cédric-Olivier Turrin, et al.
Published: (2013-08-01) -
Organophosphorus Chemistry for the Synthesis of Dendrimers
by: Jean-Pierre Majoral, et al.
Published: (2012-11-01)